FACULTY AFFILIATIONS
 |
Axel Grothey, MD
Senior Associate Consultant
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota
|
 |
Daniel G Haller, MD
Professor of Medicine
Abramson Cancer Center
at the University of Pennsylvania
Philadelphia, Pennsylvania |
 |
Nina Grenon, MS, APRN-BC,
AOCN
Adult/Geriatric Nurse Practitioner
Center for Gastrointestinal Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts |
 |
Margot F Sweed, CRNP
Nurse Practitioner
GI Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania |
CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of
CNE activities. Real or apparent conflicts of interest are identified and resolved by a peer review content
validation process. The content of each activity is reviewed by both a member of the scientific staff and
an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient
care recommendations.
The scientific staff and consultants for Research To Practice are involved in the development and review
of content for educational activities and report the following real or apparent conflicts of interest, either
current or within the past 12 months, for themselves (or their spouses/partners) that have been resolved
through a peer review process: John Brebner, Richard Kaderman, PhD, Neil Love, MD, Paula Mateo,
RN, BA, Anne O’Connor, RN, MSN, AOCN, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack,
PharmD, Fredrica Preston, RNC, NP, AOCN, Ginelle Suarez, Erin Wall and Kathryn Ault Ziel, PhD — no
real or apparent conflicts of interest to report; Aviva Asnis-Alibozek, PA-C, MPAS — salary: AstraZeneca
Pharmaceuticals LP; shareholder of AstraZeneca Pharmaceuticals LP; Sally Bogert, RNC, WHCNP
— shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education
grants from Abraxis BioScience, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals
Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc,
Genomic Health Inc, GPC Biotech, Roche Laboratories Inc and Sanofi-Aventis, who have no influence
on the content development of our educational activities.
In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of
interest that have been resolved through a peer review process:
Dr Grothey — Consulting Fees: Amgen Inc, Bristol-Myers Squibb Company, Genentech BioOncology,
Roche Laboratories Inc, Sanofi-Aventis. Ms Grenon — Consulting Fees: Sanofi-Aventis; Speaker/
Speakers Bureau: Amgen Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Haller — Consulting
Fees: Amgen Inc, Bristol-Myers Squibb Company, Genentech BioOncology, Roche Laboratories Inc,
Sanofi-Aventis, Taiho Pharmaceutical Co; Other Financial Support: Genentech BioOncology, Roche
Laboratories Inc, Sanofi-Aventis. Ms Sweed — Consulting Fees: Athena Forum; Speaker/Speakers
Bureau: Meniscus Limited, Sanofi-Aventis.
This educational activity contains discussion of published and/or investigational uses of agents that are not
indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any
agent outside of the labeled indications. Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications and warnings. The opinions expressed are those
of the presenters and are not to be construed as those of the publisher or grantors.
